December 5, 2013 Amorfix appoints Mr. Johannes Roth to Board of Directors
December 2, 2013 Amorfix to provide ALS blood test diagnostic update at the MND/ALS 24th International Symposium
November 13, 2013 Amorfix announces fiscal 2014 second quarter results
November 1, 2013 Amorfix closes private placement offering
October 24, 2013 Amorfix confirms presence of misfolded SOD1 in sporadic ALS
October 11, 2013 Amorfix announces retirement of Michael Sonnenreich
October 4, 2013 Amorfix closes first tranche of private placement offering
August 14, 2013 Amorfix reports update on lead ovarian cancer program
August 13, 2013 Amorfix announces fiscal 2014 first quarter results
August 7, 2013 Amorfix announces retirement of Meryl Chertoff
July 17, 2013 Amorfix to provide ALS diagnostic update at the MND/ALS 24th International Symposium
June 28, 2013 Amorfix announces fiscal 2013 year end results
June 26, 2013 Amorfix closes first tranche of private placement offering
June 5, 2013 Amorfix provides update on ovarian cancer preclinical studies
April 25, 2013 Amorfix to investigate lung cancer misfolded proteins for therapeutic intervention
April 22, 2013 Amorfix closes second tranche of private placement offering
April 9, 2013 Amorfix announces breakthrough scientific discovery and provides update for its ovarian cancer therapeutic antibody program
April 5, 2013 Amorfix closes private placement offering
April 3, 2013 Amorfix chief science officer to present latest on ovarian cancer therapeutic program at AACR 2013
March 20, 2013 Amorfix announces progress on ALS program
February 21, 2013 Amorfix closes private placement offering
February 14, 2013 Amorfix announces third quarter fiscal 2013 results and financing
January 31, 2013 Pharmaceutical executive Warren Whitehead joins Amorfix as chief financial officer
January 29, 2013 Amorfix and QPS to collaborate on Alzheimer's disease project
January 24, 2013 Amorfix to present cancer therapeutic program at AACR 2013
January 22, 2013 Amorfix provides update on ALS diagnostic program
January 4, 2013 Amorfix to present corporate overview at the Biotech Showcase 2013 Conference